Breaking News Bar

Business News and Information

Aratana’s stock falls after newest pet drug treatment fails study

Aratana Therapeutics Inc.'s latest drug candidate did not pass an effectiveness study in dogs.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear